Hôpital Paul Brousse

Villejuif 94800

2 studies enrolling now · 8 studies all time

What they study most

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Acute-On-Chronic Liver Failure, COVID-19, Compensated Cirrhosis, HIV Infections, Hepatitis C Virus Infection, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis, Liver Cirrhosis, Liver Diseases, Liver Transplant; Complications, Nonalcoholic Steatohepatitis, Nonalcoholic Steatohepatitis (NASH) With Fibrosis

Studies at this site

• Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis — Recruiting now
• Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs — Recruiting now
• Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients — Completed
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) — Stopped early
• SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19 — NO_LONGER_AVAILABLE
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed